Provided by Tiger Trade Technology Pte. Ltd.

Tradr 2X Long TEM Daily ETF

39.42
-0.7400-1.84%
Pre-market: 39.830.4100+1.04%07:33 EDT
Volume:110.00K
Turnover:4.57M
Market Cap:48.81M
PE:- -
High:43.31
Open:41.07
Low:39.42
Close:40.16
52wk High:152.22
52wk Low:11.52
Shares:1.24M
Float Shares:1.24M
Volume Ratio:0.50
T/O Rate:8.88%
Dividend:3.85
Dividend Rate:9.76%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

AI Stocks Are Crashing After One Terrifying Warning

AI Industry Frontlines
·
Sep 14

Anthropic Inks $13.7 Billion Computing-Power Pact With "Trump-Linked" Rum Group

Options & Short Sell
·
Sep 14

Trump Hits The Gas As Silicon Valley Reaches For The Brakes

AI Industry Frontlines
·
Sep 14

Anthropic CEO Urges Slowing The AI Model Race; Musk, Altman Voice Support

AI Industry Frontlines
·
Sep 13

Tempus AI to build multimodal whole-genome dataset for AI-driven healthcare

TIPRANKS
·
Sep 11

Tempus AI Launches Effort to Build 100,000 Whole-Genome Dataset Linked to Clinical Outcomes

Reuters
·
Sep 11

Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation

THOMSON REUTERS
·
Sep 11

Tempus AI, - General Availability of Dataset Planned for Mid-2027

THOMSON REUTERS
·
Sep 11

$1M → $7B ARR In 10Y! Databricks On Enterprise AI Moat

Bellwether Stocks Movement
·
Sep 11

Anthropic: 3 AI Economic Scenarios to 2030, 15% YoY Growth in Bull Case

AI Industry Frontlines
·
Sep 11

HSBC Says The AI Trade's Next Chapter Hinges On One Word: Monetization

Analyst Calls
·
Sep 10

Tempus AI awarded up to $9.5M from ARPA-H for autonomous AI in cardiology

TIPRANKS
·
Sep 10

Tempus AI Wins up to $9.5 Million ARPA-H Advocate Award for Autonomous Heart Failure Agent

Reuters
·
Sep 10

Tempus Secures up to $9.5 Million in Arpa-H Advocate Funding to Deploy First Autonomous AI in Cardiology

THOMSON REUTERS
·
Sep 10

Tempus AI Initiated at Neutral by UBS

Dow Jones
·
Sep 09

UBS Initiates Coverage on Tempus AI With Neutral Rating, $70 Price Target

MT Newswires Live
·
Sep 09

Tempus AI Price Target Announced at $67.00/Share by Roth Capital

Dow Jones
·
Sep 08

Rothschild & Co Redburn Initiates Tempus AI at Neutral With $67 Price Target

MT Newswires Live
·
Sep 08

Arm's Haas: AI Could Cure Cancer In Our Lifetime — If The Industry Can Build Enough Chips

AI Industry Frontlines
·
Sep 08

Kospi Down 27%, Goldman Still Says 12,000: "The Market Is Underpricing This Cycle"

Analyst Calls
·
Sep 07